Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Talkiatry
AddedFeb 15, 2024
UpdatedJun 18, 2026
Talkiatry

Talkiatry

Series B

Talkiatry: A leading tech-enabled provider of quality psychiatric care, available online or on-site.

HQ
New York City, NY, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Talkiatry, founded with the mission to make high-quality psychiatric care accessible and convenient, leverages technology to provide mental health services via telehealth and physical locations. The company's vision is to revolutionize mental health care by integrating advanced technology with compassionate care, ensuring patients receive timely and effective treatment. Talkiatry offers comprehensive psychiatric services, including medication management and therapy, catering to a broad market of individuals seeking mental health support. The company accepts a wide range of insurance plans, making their services accessible to a diverse clientele.

Notable figures affiliated with Talkiatry include experienced psychiatrists and mental health professionals dedicated to advancing the field of psychiatry through innovative care models. The company has secured investments from prominent venture capital firms, which have fueled its rapid growth and expansion. Key achievements include the successful integration of telehealth platforms, partnerships with major insurance providers, and the establishment of multiple physical locations. Talkiatry's impact is evident in its ability to provide accessible, high-quality psychiatric care to a growing number of patients, significantly improving mental health outcomes.

Talkiatry - Similar Companies

Talkspace logo

Talkspace

talkspace.com

Terapify logo

Terapify

terapify.com

Path logo

Path

pathccm.com

Medvidi logo

Medvidi

medvidi.com

Mindful Care logo

Mindful Care

mindful.care

SonderMind logo

SonderMind

sondermind.com

Access Psychiatry Solutions logo

Access Psychiatry Solutions

Foresight Mental Health logo

Foresight Mental Health

Resilience Lab logo

Resilience Lab

resiliencelab.us

Journey Clinical logo

Journey Clinical

journey.clinic

Cerebral logo

Cerebral

cerebral.com

Start Talking logo

Start Talking

starttalking.io

Mindbloom logo

Mindbloom

mindbloom.com

Calmerry logo

Calmerry

calmerry.com

BetterMynd logo

BetterMynd

Talkiatry - Quick Facts

Who are Talkiatry's competitors?

Companies similar to Talkiatry include Talkspace, Terapify, Path and Medvidi.

When was Talkiatry founded?

Talkiatry was founded in 2019.

Where is Talkiatry's headquarters located?

Talkiatry's headquarters is located in New York City, NY, US.

When was Talkiatry's last funding round?

Talkiatry's most recent funding round was for $75M (USD) in July 2022.

How much has Talkiatry raised to-date?

As of Jul 1, 2022, Talkiatry has raised a total of $112M (USD).

How many employees does Talkiatry have?

Talkiatry has 750 employees as of Feb 4, 2024.

Talkiatry - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Transactional
Customer
  • Consumers
Main Product
  • Mental Health Care
  • Psychiatric Care
  • Telehealth
  • Telehealth Services
Tags
  • Healthtech
NAICS
  • 621000Ambulatory Health Care Services
  • 621300Offices of Other Health Practitioners
  • 621330Offices of Mental Health Practitioners (except Physicians)
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified